NYSE · Materials
cbdMD, Inc. (YCBD)
As-reported financials and recent SEC filings for cbdMD, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$19.2M
Net income
$-2.0M
Net margin
-10.6%
Diluted EPS
$-1.09
ROE
-28.2%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $19.2M | $19.5M | $24.2M | $35.4M | $44.5M |
| Gross profit | $12.0M | $12.0M | $15.0M | $22.3M | $30.0M |
| Operating income | $-2.2M | $-3.3M | $-22.5M | $-78.3M | $-19.6M |
| Net income | $-2.0M | $-3.7M | $-22.9M | $-70.1M | $-23.4M |
| Diluted EPS | $-1.09 | $-2.04 | $-7.61 | $-31.89 | $-11.01 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-05-20
View on EDGAR →10-Q2026-05-14
View on EDGAR →42026-04-16
View on EDGAR →42026-04-16
View on EDGAR →42026-04-16
View on EDGAR →42026-04-16
View on EDGAR →42026-04-16
View on EDGAR →42026-04-16
View on EDGAR →Largest Materials peers
Go deeper on YCBD
Search cbdMD, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.